From the Bod website: 'Due to unprecedented demand we are currently out of stock of Pommade Devine. We apologise for this inconvenience hope to have replacement stock soon.'
ACW This biotech stock raised $11M in a risk-off environment. Its Alzheimer's drug could change the game
History-making uranium sample grades and an imminent drill run. Infini Resources is poised to transform in 2025